Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Tumor Ablation Market Achieve During 2025–2034, and What Does It Indicate?

There has been a rapid expansion in the size of the tumor ablation market in the recent past. The market which was valued at $1.45 billion in 2024, is projected to increase by 12.1% compound annual growth rate (CAGR), reaching a value of $1.62 billion in 2025. Factors that have contributed to this significant growth in the past include advancements in ablation technology that is more precise and efficient, a noted increase in healthcare spending in developing economies, a demographic trend favoring older populations, growing cancer rates, and an overall global surge in cancer prevalence.

The market size of tumor ablation is projected to experience swift expansion in the upcoming years, escalating to $2.54 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.8%. Factors contributing to this growth during the predicted period include a rise in cancer occurrence, growth in minimally invasive techniques, broadening applications, improved effectiveness of healthcare costs, and enhanced awareness and education. The forecasting period will be defined by significant trends such as progress in technology, persistent evolution of advanced ablation technologies, integration of artificial intelligence, emphasis on outpatient care settings, and patient-oriented strategies.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Tumor Ablation Market?

The surge in minimally invasive procedures is anticipated to spur the progression of the tumor ablation market. These procedures, which necessitate small or no incisions, are gaining in popularity due to their shortened recovery time, reduced risk of complications, and less post-operative discomfort compared to regular surgeries. Tumor ablation forms part of these procedures by eliminating cancerous tissues via methods such as radiofrequency, microwave, or cryoablation, with minimal damage to the nearby healthy tissues and further shortening of recovery duration. For example, in January 2024, Intuitive Surgical Inc., producing robotic items in the US, stated that they had positioned 415 da Vinci surgical systems (robotic surgical systems adopting a minimally invasive surgical method) in the final quarter of 2023, demonstrating a 12% rise compared to 2022. Therefore, the rise in minimally invasive procedures demonstrates a contributing factor to the market growth of tumor ablation.

Explore Comprehensive Insights Into The Global Tumor Ablation Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

Who Are the Key Firms Paving the Way for Growth in the Tumor Ablation Market?

Major companies operating in the tumor ablation market are:

• Abbott Laboratories

• Medtronic plc

• Siemens Healthineers AG

• Stryker Corporation

• Boston Scientific Corporation

What Are the Most Influential Trends Currently Shaping the Tumor Ablation Market?

Leading firms in the tumor ablation market are working on cutting-edge products like bone tumor ablation systems to increase treatment efficiency, boost patient results, and accommodate more types of tumors. The bone tumor ablation system is a distinct medical instrument used for treating bone tumors using minor surgical procedures. For example, in March 2024, Medtronic plc, a medical device firm based in Ireland, acquired U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. This advanced system is engineered to treat painful bone metastases and benign bone tumors such as osteoid osteoma. The OsteoCool 2.0 has the capacity for the concurrent use of four internally cooled probes, allowing doctors to ablate two vertebral bodies concurrently or create larger ablation areas in non-spinal applications. With a delivery of 20W per channel, it has over double the power of the Stryker OptaBlate bone tumor ablation system.

Secure Your Global Tumor Ablation Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Which Primary Segments of the Tumor Ablation Market Are Driving Growth and Industry Transformations?

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation

2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer

4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:

1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)

2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Which Regions Are Essential for the Growth of the Tumor Ablation Market?

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Tumor Ablation Market Impacting Future Growth?

Tumor ablation is a minimally invasive medical procedure used to destroy cancerous tissues. It involves the application of extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This technique is often employed for small tumors or those in difficult-to-reach locations.

Browse Through More Similar Reports By The Business Research Company:

Intratumoral Cancer Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: